StockData
COMPASS Pathways plc logo

COMPASS Pathways plc (CMPS) stock

CMPSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 1/30
$8.12+0.14 (+1.75%)

Close on Nov 18, 2026Market cap $1.12BP/E –Yield –

COMPASS Pathways free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

COMPASS Pathways's free cash flow for the twelve months ending Dec 31, 2024 was -$119.19M. For fiscal 2024 it was -$119.19M. The highest annual figure on record is -$17.98M in fiscal 2019.

Annual free cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$119.19M–
FY2023Dec 31, 2023-$97.44M–
FY2022Dec 31, 2022-$106.05M–
FY2021Dec 31, 2021-$68.08M–
FY2020Dec 31, 2020-$41.51M–
FY2019Dec 31, 2019-$17.98M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024-$41.76M–
Q3 FY2024Sep 30, 2024-$22.19M–
Q2 FY2024Jun 30, 2024-$34.42M–
Q1 FY2024Mar 31, 2024-$20.83M–
Q4 FY2023Dec 31, 2023-$27.78M–
Q3 FY2023Sep 30, 2023-$17.08M–
Q2 FY2023Jun 30, 2023-$24.83M–
Q1 FY2023Mar 31, 2023-$27.75M–
Q4 FY2022Dec 31, 2022-$45.41M–
Q3 FY2022Sep 30, 2022-$19.02M–
Q2 FY2022Jun 30, 2022-$18.42M–
Q1 FY2022Mar 31, 2022-$23.21M–
Q4 FY2021Dec 31, 2021-$22.46M–
Q3 FY2021Sep 30, 2021-$13.98M–
Q2 FY2021Jun 30, 2021-$17.79M–
Q1 FY2021Mar 31, 2021-$13.85M–
Q4 FY2020Dec 31, 2020-$16.78M–
Q3 FY2020Sep 30, 2020-$13.92M–

More COMPASS Pathways figures

See a number that looks wrong?